Victhom announces Tier classification change

QUEBEC, Jan. 22, 2013 /CNW Telbec/ - Victhom Human Bionics Inc. ("Victhom") (TSXV: VHB) announced that, effective the close of trading today January 22, 2013, Victhom's Tier classification changed from Tier 1 to Tier 2. Victhom's Tier classification has changed from Tier 1 to Tier 2 because it has not maintained the TSX Venture Exchange's Tier 1 continued listing requirements.

About Victhom

Victhom is a company which owns patents in the field of orthotics and prosthetics ("O&P"), including intellectual property used in the POWER KNEE, the world's first and only motor-powered prosthesis for above-knee amputees, a product distributed under license agreement by Ossur, a global leader in the O&P market. Victhom has also a royalty agreement related to neuromodulation products that are still at the development stage, with Neurostream Technologies, a General Partnership owned by Otto Bock, a global leader in the O&P market.

FORWARD-LOOKING STATEMENTS

Some of the statements made herein may constitute forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause Victhom's actual results, performance or achievements to be materially different from those expressed or implied by any of Victhom's statements. Actual events or results may differ materially. We disclaim any intention, and assume no obligation, to update these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE VICTHOM HUMAN BIONICS INC.

Copyright 2013 Canada NewsWire

Grafico Azioni Victhom Human Bionics Inc. (TSXV:VHB)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Victhom Human Bionics Inc.
Grafico Azioni Victhom Human Bionics Inc. (TSXV:VHB)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Victhom Human Bionics Inc.